BRAF and thyroid cancer: However, understanding of the molecular basis of pathogenesis and progression in thyroid cancer has progressed.4 Genetic mutations in genes such as BRAF, and RAS are associated with both the pathogenesis of DTC and prognosis of thyroid cancer.5 In the era of precision medicine, personalized treatment according to potential prognosis for individuals with thyroid cancer is critically important.